Department of Defense Grant: Innovations in Care and Support for Alzheimer’s and TBI

The intent of the FY20 PRARP InCASA is to support innovative and impactful research that improves the quality of life and care for individuals, families, and care providers living with the common symptoms of TBI and/or AD/ADRD, as related to the PRARP’s mission (see Section II.A, Program Description). The proposed work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the contexts of the PRARP’s mission and vision. This can include innovations and research for symptom reduction (e.g., cognitive, behavioral, function, mood), resiliency factors, increasing or maintaining independence, and support for families and care providers. The application should also demonstrate the study team’s experience in both TBI and/or AD/ADRD research, as appropriate. Given the patient-centered intent of the FY20 PRARP InCASA, animal research is prohibited. The research innovation and impact for the FY20 PRARP InCASA are expected to benefit the military, Veteran, and civilian communities. FY20 PRARP InCASA applications must be Innovation- and Impact-based.